A Study to Evaluate Alnuctamab in Combination With Mezigdomide in Participants With Relapsed and/or Refractory Multiple Myeloma

Conditions: Multiple Myeloma Interventions: Drug: Alnuctamab; Drug: Mezigdomide; Drug: Dexamethasone Sponsors: Celgene Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials